Price (delayed)
$37.74
Market cap
$19.11B
P/E Ratio
N/A
Dividend/share
$1.16
EPS
-$5.65
Enterprise value
$34.31B
Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, it has been operating
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.